Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality

Stroke

Volumn 28, Issue 4, 1997, Pages 816-821

  Heywood, Daniella M ^a,c   Carter, Angela M ^a   Catto, Andrew J ^a   Bamford, John M ^a,b   Grant, Peter J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

acute; coagulation; polymorphism (genetics); stroke

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SMOKING; STROKE;

EID: 0030932636     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.4.816     Document Type: Article

References (38)

1. Broze GJ Jr, Majerus PW. Purification and properties of human coagulation factor VII. J Biol Chem. 1980;255:1242-1247.
2. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry. 1991;30:10819-10824.
3. Grant PJ, Prentice CRM. Coronary artery disease. In: Bloom AL, Forbes CD, Thomas DP, Tuddenam EDG, eds. Haemostasis, Thrombosis. 3rd ed. Edinburgh, Scotland: Churchill Livingstone; 1994:1231-1254.
4. Meade TW, Mellows S, Brovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
5. Johnson O, Mellbring G, Nilsson T. Defective fibrinolysis in survivors of myocardial infarction. Int J Cardiol. 1984;6:380-382.
6. Heinrich J, Balleisen L, Schulte H, Assmann G, Van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
7. Balleisen L, Schulte H, Assman G, Epping PH, Van de Loo J. Coagulation factors and the progress of coronary heart disease. Lancet. 1987;2:461.
8. Meade TW, North WRS, Chakrabarti RR, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980;1:1050-1054.
9. Takano K, Yamaguchi T, Okada Y, Uchida K, Kisiel W, Kato H. Hypercoagulability in acute ischaemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. Thromb Res. 1990;58:481-491.
10. Green F, Kellener C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb. 1991;11:540-546.
11. Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart diseases. Atherosclerosis. 1992;94:44-50.
12. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb. 1994;4:193-198.
13. Saha N, Liu Y, Heng CK, Hong S, Low PS, Tay JSH. Association with factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides. Arterioscler Thromb. 1994;14:1923-1927.
14. Meilahn E, Ferrell R, Kiss J, Temple A, Green F, Humphries S, Kuller L. Genetic determination of coagulation factor VIIc levels among healthy middle-aged women. Thromb Haemost. 1995;73:623-625.
15. Kario K, Narita N, Matsuo T, Kayaba K, Tsutsumi A, Matsuo M, Miyata T, Shimada K. Genetic determinants of plasma factor VII activity in the Japanese. Thromb Haemost. 1995;73:617-622.
16. Heywood DM, Mansfield MW, Grant PJ. Factor VII gene polymorphisms, factor VII:C levels, and features of insulin resistance in non-insulin-dependent diabetes mellitus. Thromb Haemost. 1996; 75:401-406.
17. 353Gln polymorphism in the factor VII gene results from defective secretion. Blood. 1994;86:86. Abstract.
18. Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5″ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet. 1993;90: 575-576.
19. Mariani G, Marchetti G, Arcieri P, Bernardi F. The role of factor VII gene polymorphisms in determining FVII activity and antigen plasma level variation. Blood. 1994;86:86. Abstract.
20. Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW. Assay of factor VII activity by two techniques: evidence of increased conversion of VII to αVII in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol. 1985;59:249-258.
21. Simpson HCR, Meade TW, Stirling Y, Mann JI, Chakrabarti R, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet. 1983;1:786-790.
22. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma FVII is activated by postprandial triglyceridaemia irrespective of dietary fat composition. Atherosclerosis. 1991;86:163-171.
23. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII: putative cardiovascular risk factors. Atherosclerosis. 1991;91:191-205.
24. Dube RK, Rao PVB, Saha PK, Katiyar BC, Dube B. Blood coagulation and fibrinolysis in haemorrhagic stroke. Thromb Haemost. 1978;39:84-88.
25. Catto A, Carter AM, Barrett J, Stickland M, Bamford J, Davies A, Grant PJ. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke. 1996;27:435-440.
26. Catto A, Carter A, Ireland H, Bayston TA, Philippou H, Barrett J, Lane DA, Grant PJ. Factor V leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol. 1995;15:783-785.
27. Bamford J. Clinical examination in diagnosis and subclassification of stroke. Lancet. 1992;339:400-402.
28. Kario K, Matsuo T, Asada R, Sakata T, Kato H, Miyata T. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level. Thromb Haemost. 1995;73:429-434.
29. Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van de Loo J, Kienast J, Wu KK, Morrissey JH, Meade TW, Martin JC, Cooper JA, Finch A. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost. 1994;71:38-48.
30. Mansfield MW, Stickland MH, Carter A, Grant PJ. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes and in patients with diabetic retinopathy. Thromb Haemost. 1994;71:731-736.
31. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity. 1974;33:229-239.
32. Baumann RE, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum Genet. 1994;94:165-170.
33. Dennis M, Bamford JM, Sandercock P, Molyneux A, Warlow C. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke. 1989;20:789-794.
34. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara R, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke: the Framingham Study. JAMA. 1981;245:1225-1229.
35. Shinton R, Beevers G. Meta analysis between cigarette smoking and stroke. Br Med J. 1989;298:789-794.
36. 353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis. 1996;119:119-127.
37. Heywood DM, Ossei-Gerning N, Grant PJ. Association of factor VII:C levels with environmental and genetic factors in patients with ischaemic heart disease and coronary atheroma characterised by angiography. Thromb Haemost. 1996;2:161-165.
38. Butterworth RJ, Bath PMW, Marshall WJ. Measurements of lipid profiles. Cerebrovasc Dis. 1995;5:230. Abstract.